Plasma Cell Leukemia - 22 Studies Found
Not yet recruiting |
: Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma :
:
|
Recruiting |
: SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy :
|
Recruiting |
: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) :
|
Terminated |
: Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma :
: 2012-08-03 :
|
Completed |
: Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia : Multiple Myeloma and Plasma Cell Neoplasm : 2005-11-22 :
|
Recruiting |
: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia :
|
Not yet recruiting |
: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases :
|
Recruiting |
: Allo HSCT Using RIC for Hematological Diseases :
|
Recruiting |
: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep :
|
Recruiting |
: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies :
|